Skip to main content

S 9852 — New York

Relates to designated or rescheduled drugs

Introduced 2025-2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.

Official abstract, as published by the legislature.

  • S 9852 is a bill in the New York Senate, 2025-2026 session, introduced April 8, 2026.
  • Sponsored by Jessica Scarcella-Spanton, with 3 cosponsors.
  • Current status: introduced.
  • Most recent action (April 8, 2026): REFERRED TO HEALTH.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Jessica Scarcella-Spanton

Cosponsors (3): John Liu, Shelley Mayer, James Sanders Jr.

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed Assembly, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate REFERRED TO HEALTH Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›